Comparative Evaluation of Mouse Bone Marrow Mesenchymal Stromal Cells Characteristics Cultured in Two Different Supplemented Media
Main Article Content
Abstract
Introduction: Preclinical studies on mesenchymal stromal cells (MSC) have allowed the cells to be considered as a promising candidate for cellular therapy. In recent years, conflicting data have been reported regarding various aspects of their characteristics, development and differentiation potential, which may be due to arrange of factors. Among the factors worth investigating is the culture medium formulation. Methods: Here we have made a comparative characterization of mouse bone marrow mesenchymal stromal cells (mBM-MSC) that were cultured using two common supplements, MesenCult™ Stimulatory Supplement (MSS) and fetal bovine serum (FBS), under the same experimental conditions at different passages. Clonogenic potential, cumulative population doubling level (CPDL), population doubling time (PDT), immunophenotyping, differentiation, immunosuppression potentials and chromosome analysis of early and late passages mBM-MSC were assessed. Results: Our findings showed that the CPDL, immunophenotype and immunosuppression potential of mBM-MSC were similar. However, variations were seen in their clonogenicity, population doubling time and differentiation efficacy whereby all of these were enhanced in DMSS. These observations suggest that their genetic make-up may be affected by both supplements upon prolonged culture. Interestingly, this conjecture was supported when chromosomal analysis revealed genetic instability of mBM-MSCs cultured in both supplements. Conclusion: In conclusion, culture medium formulation was shown to cause variations and spontaneous transformation in mBM-MSCs raising concerns on the usage of late passages mBM-MSCs in fundamental and preclinical downstream experiments.
Downloads
Article Details
References
Nakao N, Nakayama T, Yahata T, Muguruma Y, Saito S, Miyata Y, et al. Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: Advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol [Internet]. 2010 Aug 1 [cited 2020 Sep 3];177(2):547–54. Available from: http://rsb.info.nih.gov/ij/download/
Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease [Internet]. Vol. 8, Nature Reviews Immunology. Nature Publishing Group; 2008 [cited 2020 Sep 3]. p. 726–36. Available from: https://www.nature.com/articles/nri2395
Ren G, Zhao X, Zhang L, Zhang J, L’Huillier A, Ling W, et al. Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression. J Immunol [Internet]. 2010 Mar 1 [cited 2020 Sep 3];184(5):2321–8. Available from: http://www.jimmunol.org/content/184/5/2321http://www.jimmunol.org/content/184/5/2321.full#ref-list-1
Fei X, Jiang S, Zhang S, Li Y, Ge J, He B, et al. Isolation, Culture, and Identification of Amniotic Fluid-Derived Mesenchymal Stem Cells. Cell Biochem Biophys [Internet]. 2013 Mar 19 [cited 2020 Sep 3];67(2):689–94. Available from: https://link.springer.com/article/10.1007/s12013-013-9558-z
Vellasamy S, Sandrasaigaran P, Vidyadaran S, Abdullah M, George E, Ramasamy R. Mesenchymal stem cells of human placenta and umbilical cord suppress T-cell proliferation at G0 phase of cell cycle. Cell Biol Int. 2013 Mar;37(3):250–6.
Banas A. Purification of adipose tissue mesenchymal stem cells and differentiation toward hepatic-like cells. Methods Mol Biol [Internet]. 2012 [cited 2020 Sep 3];826:61–72. Available from: https://link.springer.com/protocol/10.1007/978-1-61779-468-1_6
Klinker MW, Marklein RA, Lo Surdo JL, Wei CH, Bauer SR. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2598–607.
Brunel M, Herr F, Durrbach A. Immunosuppressive Properties of Mesenchymal Stem Cells. Curr Transplant Reports [Internet]. 2016 Dec 19 [cited 2020 Sep 3];3(4):348–57. Available from: https://link.springer.com/article/10.1007/s40472-016-0120-y
Drela K, Stanaszek L, Nowakowski A, Kuczynska Z, Lukomska B. Experimental strategies of mesenchymal stem cell propagation: Adverse events and potential risk of functional changes. Vol. 2019, Stem Cells International. Hindawi Limited; 2019.
Hackett CH, Flaminio MJBF, Fortier LA. Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow. Stem Cells Dev [Internet]. 2011 Apr 1 [cited 2020 Sep 3];20(4):721–35. Available from: /pmc/articles/PMC3128771/?report=abstract
Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood [Internet]. 2004 Mar 1 [cited 2020 Sep 3];103(5):1662–8. Available from: https://pubmed.ncbi.nlm.nih.gov/14592819/
Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc [Internet]. 2009 [cited 2020 Sep 3];4(1):102–6. Available from: https://pubmed.ncbi.nlm.nih.gov/19131962/
Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WWK, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med [Internet]. 1999 [cited 2020 Sep 3];5(3):309–13. Available from: https://pubmed.ncbi.nlm.nih.gov/10086387/
Even MS, Sandusky CB, Barnard ND. Serum-free hybridoma culture: Ethical, scientific and safety considerations. Trends Biotechnol [Internet]. 2006 [cited 2020 Sep 3];24(3):105–8. Available from: https://pubmed.ncbi.nlm.nih.gov/16427150/
Maertens L, Erpicum C, Detry B, Blacher S, Lenoir B, Carnet O, et al. Bone Marrow-Derived Mesenchymal Stem Cells Drive Lymphangiogenesis. Rameshwar P, editor. PLoS One [Internet]. 2014 Sep 15 [cited 2020 Sep 3];9(9):e106976. Available from: https://dx.plos.org/10.1371/journal.pone.0106976
Qian H, Le Blanc K, Sigvardsson M. Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein. J Biol Chem [Internet]. 2012 Jul 27 [cited 2020 Sep 3];287(31):25795–807. Available from: /pmc/articles/PMC3406666/?report=abstract
Pochampally R. Colony forming unit assays for MSCs. Methods Mol Biol [Internet]. 2008 [cited 2020 Sep 3];449:83–91. Available from: https://pubmed.ncbi.nlm.nih.gov/18370085/
Kim HR, Lee J, Byeon JS, Gu NY, Lee J, Cho IS, et al. Extensive characterization of feline intra-abdominal adipose-derived mesenchymal stem cells. J Vet Sci [Internet]. 2017 [cited 2020 Sep 3];18(3):299–306. Available from: /pmc/articles/PMC5639082/?report=abstract
Sreejit P, Dilip KB, Verma RS. Generation of mesenchymal stem cell lines from murine bone marrow. Cell Tissue Res [Internet]. 2012 Oct 27 [cited 2020 Sep 3];350(1):55–68. Available from: https://link.springer.com/article/10.1007/s00441-012-1458-9
Jin L, Ji S, Shen M, Zhang J, Han J, Ni J. Expansion, characterization, and differentiation of rabbit bone marrow-derived mesenchymal stem cells in serum-free medium. Animal Cells Syst (Seoul) [Internet]. 2014 Jul 4 [cited 2020 Sep 3];18(4):228–36. Available from: http://www.tandfonline.com/doi/abs/10.1080/19768354.2014.929026
Lee MS, Youn C, Kim JH, Park BJ, Ahn J, Hong S, et al. Enhanced cell growth of adipocyte-derived mesenchymal stem cells using chemically-defined serum-free media. Int J Mol Sci [Internet]. 2017 Aug 16 [cited 2020 Sep 3];18(8). Available from: /pmc/articles/PMC5578168/?report=abstract
Sargent B. Cell Culture Basics: Stem Cell Media – The “What” and “Why” - Cell Culture Dish [Internet]. 2016 [cited 2020 Sep 3]. Available from: https://cellculturedish.com/cell-culture-basics-stem-cell-media-the-what-and-why/
Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-Mesenchymal Transitions in Development and Disease. Vol. 139, Cell. Cell Press; 2009. p. 871–90.
Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Vol. 9, Nature Reviews Cancer. 2009. p. 265–73.
Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: Epithelial mesenchymal transitions as a paradigm [Internet]. Vol. 103, Blood. American Society of Hematology; 2004 [cited 2020 Sep 3]. p. 2892–9. Available from: https://ashpublications.org/blood/article-pdf/103/8/2892/1698614/zh800804002892.pdf
Rubio D, Garcia S, De la Cueva T, Paz MF, Lloyd AC, Bernad A, et al. Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res. 2008 Feb 15;314(4):691–8.
Abedian Z, Akhavan Niaki H, Zabihi E, Feizi F, Pourbagher R, Mostafaei A, et al. Spontaneous Mesenchymal to Epithelial Like Tissue Transition (MET) in a Long Term Human Skin Culture [Internet]. Vol. 3, International Biological and Biomedical Journal. International Biological and Biomedical Journal; 2017 [cited 2020 Sep 3]. Available from: http://ibbj.org/article-1-112-en.html
Ooi YY. Immunophenotype and differentiation capacity of bone marrow-derived mesenchymal stem cells from CBA/Ca, ICR and Balb/c mice. World J Stem Cells [Internet]. 2013 [cited 2020 Sep 3];5(1):34. Available from: /pmc/articles/PMC3557349/?report=abstract
Lv FJ, Tuan RS, Cheung KMC, Leung VYL. Concise review: The surface markers and identity of human mesenchymal stem cells. Vol. 32, Stem Cells. Wiley-Blackwell; 2014. p. 1408–19.
Wang W, Li P, Li W, Jiang J, Cui Y, Li S, et al. Osteopontin activates mesenchymal stem cells to repair skin wound. Dettman RW, editor. PLoS One [Internet]. 2017 Sep 28 [cited 2020 Sep 3];12(9):e0185346. Available from: https://dx.plos.org/10.1371/journal.pone.0185346
Naor D, Sionov RV, Ish-Shalom D. CD44: Structure, function, and association with the malignant process [Internet]. Vol. 71, Advances in Cancer Research. Academic Press Inc.; 1997 [cited 2020 Sep 3]. p. 241–319. Available from: https://pubmed.ncbi.nlm.nih.gov/9111868/
Lavasani M, Pollett JB, Usas A, Thompson SD, Pollett AF, Huard J. The Microenvironment-Specific Transformation of Adult Stem Cells Models Malignant Triton Tumors. Asakura A, editor. PLoS One [Internet]. 2013 Dec 9 [cited 2020 Sep 3];8(12):e82173. Available from: https://dx.plos.org/10.1371/journal.pone.0082173
Simons K, Toomre D. Lipid rafts and signal transduction [Internet]. Vol. 1, Nature Reviews Molecular Cell Biology. European Association for Cardio-Thoracic Surgery; 2000 [cited 2020 Sep 3]. p. 31–9. Available from: https://www.nature.com/articles/35036052
tefanová I, Hořejší V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science (80- ) [Internet]. 1991 Nov 15 [cited 2020 Sep 3];254(5034):1016–9. Available from: http://science.sciencemag.org/
Chou DB, Sworder B, Bouladoux N, Roy CN, Uchida AM, Grigg M, et al. Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection . J Leukoc Biol [Internet]. 2012 Jul [cited 2020 Sep 3];92(1):123–31. Available from: /pmc/articles/PMC3382309/?report=abstract
Nishihira S, Okubo N, Takahashi N, Ishisaki A, Sugiyama Y, Chosa N. High-cell density-induced VCAM1 expression inhibits the migratory ability of mesenchymal stem cells. Cell Biol Int [Internet]. 2011 May 1 [cited 2020 Sep 3];35(5):475–81. Available from: https://pubmed.ncbi.nlm.nih.gov/21073443/
Jung EM, Kwon O, Kwon K-S, Cho YS, Rhee SK, Min J-K, et al. Evidences for correlation between the reduced VCAM-1 expression and hyaluronan synthesis during cellular senescence of human mesenchymal stem cells. Biochem Biophys Res Commun [Internet]. 2011 Jan 7 [cited 2020 Sep 3];404(1):463–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0006291X1002228X
Halfon S, Abramov N, Grinblat B, Ginis I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011 Jan 1;20(1):53–66.
Segers VFM, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJML, et al. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: Activators and mechanisms. Am J Physiol - Hear Circ Physiol [Internet]. 2006 Apr [cited 2020 Sep 3];290(4):1370–7. Available from: www.ajpheart.org
Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells [Internet]. Vol. 110, Blood. Blood; 2007 [cited 2020 Sep 3]. p. 3499–506. Available from: https://pubmed.ncbi.nlm.nih.gov/17664353/
Ren G, Su J, Zhang L, Zhao X, Ling W, L’huillie A, et al. Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression. Stem Cells [Internet]. 2009 Aug 1 [cited 2020 Sep 3];27(8):1954–62. Available from: http://doi.wiley.com/10.1002/stem.118
Yang ZX, Han Z-B, Ji YR, Wang YW, Liang L, Chi Y, et al. CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties. Vergani A, editor. PLoS One [Internet]. 2013 Mar 12 [cited 2020 Sep 3];8(3):e59354. Available from: https://dx.plos.org/10.1371/journal.pone.0059354
Ren Z, Wang J, Zhu W, Guan Y, Zou C, Chen Z, et al. Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro. Exp Cell Res. 2011;317(20):2950–7.
Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, et al. Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation. Stem Cells [Internet]. 2006 Apr 1 [cited 2020 Sep 3];24(4):1095–103. Available from: https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1634/stemcells.2005-0403
Lye KL, Nordin N, Vidyadaran S, Thilakavathy K. Mesenchymal stem cells: From stem cells to sarcomas. Cell Biol Int [Internet]. 2016 Jun 1 [cited 2020 Sep 3];40(6):610–8. Available from: http://doi.wiley.com/10.1002/cbin.10603
Oeseburg H, De Boer RA, Van Gilst WH, Van Der Harst P. Telomere biology in healthy aging and disease [Internet]. Vol. 459, Pflugers Archiv European Journal of Physiology. Springer; 2010 [cited 2020 Sep 3]. p. 259–68. Available from: /pmc/articles/PMC2801851/?report=abstract
He JP, Hao Y, Wang XL, Yang XJ, Shao JF, Guo FJ, et al. Review of the molecular pathogenesis of osteosarcoma [Internet]. Vol. 15, Asian Pacific Journal of Cancer Prevention. Asian Pacific Organization for Cancer Prevention; 2014 [cited 2020 Sep 3]. p. 5967–76. Available from: https://pubmed.ncbi.nlm.nih.gov/25124559/